Posted by Mark J. Miller on January 12, 2013 10:31 AM
During both of President Obama's election bids, supporters received emails every few days asking for donations to help the cause, even it was just a couple of bucks. And in the wake of his initial victory, donors gladly gave more to help fund his inauguration. Obama capped personal donations at $50,000, however, and no corporate donations were allowed.
Monday's inauguration was quite a different story, with corporations throwing in a reported total of $50 million to make it all happen after an election campaign that cost more than $1 billion. (Lobbyists and political action committees remained excluded from the inaugural funding process.)
As a result, Washingtonians saw visitors wandering around the city with bags sporting the inaugural seal on one side and the AT&T logo on the other. AT&T forked over a good deal of money to be an official sponsor, even though the company's political wing gave $5,000 to the Romney campaign and company chairman Randall Stephenson gave $30,000 to the Republican National Committee last year.
Other corporations that donated to the inauguration included Southern Company, United Therapeutics, Centene Corp., Financial Innovations, Inc., Genentech, Microsoft, and Stream Line Circle, LLC, Politico reported.Continue reading...
Posted by Shirley Brady on April 30, 2012 05:15 PM
Angry Birds Space sets mobile download record.
Apple and Microsoft face price-gouging inquiry in Australia.
Barack Obama tests "Forward" as a campaign slogan.
BP will pay $4 billion on new oil rigs in the Gulf of Mexico this year.
BlackBerry will be in the hot seat at BlackBerry World conference by RIM on Tuesday.
Broadway tests autism-friendly theater performances.
Brooklyn Nets unveils new team logo designed by Jay-Z.
Chrysler boosts Jeep production.
Facebook will announce a "life-saving tool" on Good Morning America on Tuesday.Continue reading...
Posted by Barry Silverstein on February 22, 2012 01:25 PM
Battling counterfeit products is one of a brand's biggest headaches. More often than not, counterfeiting strikes luxury and accessory brands, since it is easier to sell fake branded handbags, shoes, and clothes online and in flea markets and bazaars around the world. But what about when buying a knock-off has life-or-death implications?
Fake products are penetrating an even more serious category than luxury goods — pharmaceuticals. America's Food and Drug Administration just announced the findings of the agency’s investigation of fake vials of the cancer drug Avastin that have showed up in California, Illionis, and Texas.
The FDA's tests indicated the vials did not contain Avastin's active ingredient, and traced the phony drug to the U.K. via a distributor in Tennessee. Reuters reported that the fake Avastin apparently originated in Cairo, Egypt and went from there through Switzerland to Britain. While the FDA was warned about the products by British officials late last year, it only confirmed that they were counterfeit last week. Cancer patients and medical practitioners, understandably, are up in arms.Continue reading...
Posted by Sheila Shayon on November 21, 2011 01:01 PM
As CBS News notes, breast cancer patients are "dismayed" at the FDA's decision to pull Roche's Avastin drug for breast cancer treatment in the U.S.
The blockbuster drug will no longer be available for treatment of advanced breast cancer, a blow to women with the disease who have been lobbying to keep the drug available as an option when all others have failed. The drug remains on the market to treat colon, lung, kidney, and brain cancers.
"I did not come to this decision lightly," stated FDA commissioner Dr. Margaret Hamburg. "Sometimes despite the hopes of investigators, patients, industry and even the FDA itself, the results of rigorous testing can be disappointing."
“We are disappointed with the outcome. We remain committed to the many women with this incurable disease and will continue to provide help through our patient support programs to those who may be facing obstacles to receiving their treatment in the United States,” commented Hal Barron, M.D., chief medical officer and head, Global Product Development at Roche, which makes the cancer drug through its Genentech division. “Despite today’s action, we will start a new Phase III study of Avastin in combination with paclitaxel in previously untreated metastatic breast cancer and will evaluate a potential biomarker that may help identify which people might derive a more substantial benefit from Avastin.” Continue reading...
Posted by Shirley Brady on June 27, 2011 06:00 PM
Anheuser-Busch top marketer exits for AT&T.
Coca-Cola raises prices.
EA applauds US Supreme Court decision to strike down California's ban on violent videogame sales.
Foursquare secures another $50M in capital, adds Ritz-Carlton concierge check-ins.
Genentech lobbies FDA on behalf of Avastin breast cancer drug.
Google expands +1 functionality.
J&J to link up product marketing; admits unit name change won't change anything.Continue reading...
Posted by Dale Buss on April 8, 2011 09:00 AM
Citi says every single major automaker is a "sell" thanks to Japan supply/disruption issues as Honda faces US slowdown as parts-strapped Toyota cancels overtime at UK plants.
Audi to offer limited-edition “halo” cars to haunt BMW.
Dancing with the Stars faces heat over dancer's Playboy cover.
Dell increases investment in cloud computing.
Expedia plans to spin off TripAdvisor.
Genentech gets help from patients in Avastin fight.Continue reading...
Posted by Dale Buss on December 17, 2010 09:00 AM
Amazon can’t dent iTunes.
BMO Financial to acquire Wisconsin bank Marshall & Ilsley.
Carnival Cruise sponsors Times Square confetti drop.
Citigroup opens prototype “bank of the future” in Manhattan.
Denny’s wins big through promotion with AARP.
Genentech is expected to appeal the FDA’s decision on Avastin for breast cancer.Continue reading...
Posted by Shirley Brady on September 21, 2010 06:30 PM
Twitter fixed a security bug that disabled its website version today, and plans to step up promoted tweets (as only one-fifth of its 160 million registered users follow brands or companies).
Adobe misses earnings forecast on sluggish sales.
AIG nears sale of two units to Prudential.
BlackBerry-maker RIM could unveil its tablet (nickname: the BlackPad) as early as next week.
Clorox unloads its STP and Armor-All brands.
DC Entertainment's non-publishing business is moving to Los Angeles as part of Time Warner shake-up.
Disney former executive assistant pleads guilty to insider trading charges.
GlaxoSmithKline sues Roche, Genentech over cancer drug patent.Continue reading...